185 related articles for article (PubMed ID: 25894843)
1. Homotaurine in Parkinson's disease.
Ricciardi L; De Nigris F; Specchia A; Fasano A
Neurol Sci; 2015 Sep; 36(9):1581-7. PubMed ID: 25894843
[TBL] [Abstract][Full Text] [Related]
2. Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
Eggert K; Öhlwein C; Kassubek J; Wolz M; Kupsch A; Ceballos-Baumann A; Ehret R; Polzer U; Klostermann F; Schwarz J; Fuchs G; Jost W; Albert A; Haag A; Hermsen A; Lohmüller K; Kuhn K; Wangemann M; Oertel WH;
Clin Neuropharmacol; 2014; 37(4):116-22. PubMed ID: 24992083
[TBL] [Abstract][Full Text] [Related]
3. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial.
Ondo WG; Fayle R; Atassi F; Jankovic J
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1636-9. PubMed ID: 16291885
[TBL] [Abstract][Full Text] [Related]
4. Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease.
Zibetti M; Rizzone M; Merola A; Angrisano S; Rizzi L; Montanaro E; Cicolin A; Lopiano L
Acta Neurol Scand; 2013 May; 127(5):e28-32. PubMed ID: 23311399
[TBL] [Abstract][Full Text] [Related]
5. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
[TBL] [Abstract][Full Text] [Related]
6. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
7. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
[TBL] [Abstract][Full Text] [Related]
8. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Smith KM; Eyal E; Weintraub D;
JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
[TBL] [Abstract][Full Text] [Related]
9. Snoring is associated with an impaired motor function, disease severity and the quality of life but not with excessive daytime sleepiness in patients with Parkinson's disease.
Suzuki K; Miyamoto M; Miyamoto T; Suzuki S; Watanabe Y; Numao A; Iwanami M; Tatsumoto M; Sada T; Kadowaki T; Hashimoto K; Sakuta H; Hirata K
Intern Med; 2013; 52(8):863-9. PubMed ID: 23583989
[TBL] [Abstract][Full Text] [Related]
10. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Vu TC; Nutt JG; Holford NH
Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
[TBL] [Abstract][Full Text] [Related]
11. Sleepiness in Parkinson's disease: a controlled study.
Brodsky MA; Godbold J; Roth T; Olanow CW
Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
13. Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment.
Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Vanacore N; Meco G
Neurol Sci; 2003 Oct; 24(3):178-9. PubMed ID: 14598075
[TBL] [Abstract][Full Text] [Related]
14. Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease.
Vu TC; Nutt JG; Holford NH
Br J Clin Pharmacol; 2012 Aug; 74(2):284-95. PubMed ID: 22300470
[TBL] [Abstract][Full Text] [Related]
15. Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial.
Videnovic A; Klerman EB; Wang W; Marconi A; Kuhta T; Zee PC
JAMA Neurol; 2017 Apr; 74(4):411-418. PubMed ID: 28241159
[TBL] [Abstract][Full Text] [Related]
16. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.
Ferreira JJ; Desboeuf K; Galitzky M; Thalamas C; Brefel-Courbon C; Fabre N; Senard JM; Montastruc JL; Sampaio C; Rascol O
Eur J Neurol; 2006 Mar; 13(3):209-14. PubMed ID: 16618334
[TBL] [Abstract][Full Text] [Related]
17. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
[TBL] [Abstract][Full Text] [Related]
18. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
[TBL] [Abstract][Full Text] [Related]
19. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.
Högl B; Seppi K; Brandauer E; Glatzl S; Frauscher B; Niedermüller U; Wenning G; Poewe W
Mov Disord; 2003 Mar; 18(3):319-323. PubMed ID: 12621636
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
